Published date: 2024-07-17 15:06:36
CAS number: 1374853-91-4
Name: Pembrolizumab
Price:
$450.0/10mg
$700.0/25mg
Purity: 98.0%
Stocking period: 3 Day
Stock: 3
Product Webpage: https://www.dcchemicals.com/product_show-Pembrolizumab.html
Detail Product Information:
Pembrolizumab (anti-PD-1) is a potent, highly selective, fully humanized immunoglobulin (Ig) G4-kappa monoclonal antibody against PD-1 with potential immune checkpoint inhibitory and antineoplastic activities.
Name: DC Chemicals Limited Recommended
Chemsrc Level: Verified
Product #: 34949
Tel: 58447131
Address: Jinyu Rd100, pudong
Area: China(Mainland)
Contact: Tony Cao
Contact Phone #: 13564518121
Email: sales@dcchemicals.com
Website: http://www.dcchemicals.com
Detail
introduction:
D&C Chemicals provides a wide range of research chemicals and biochemicals including novel life-science reagents, reference compounds, APIs and Natural compounds for laboratory and scientific use.
D&C Chem has established a global network of thousands of customers from many research centers and Reagent companies in the USA, Europe and Japan.
We are the the official vendor of more than 500 universities and institutes including: Harvard University,Yale University,NIH/NCI, City of Hope ORG, PARTNERS ORG,John Hopkins University,Universit tsklinikum,Oxford University,Newcastle University,UNC,UCSF and many other universities and institutes. Our bioactive compounds received good feedback from our customers.
Our credo is committed to the adoption of different products, reliable quality, competitive prices and quality service to create value for customers.
Name: Shanghai Nianxing Industrial Co., Ltd
Area: China
Price:
$450.0/10mg
$700.0/25mg
Contact: Huang
Product Detail: Pembrolizumab
Name: DC Chemicals Limited
Area: China
Price:
$450.0/10mg
$700.0/25mg
Contact: Tony Cao
Product Detail: Pembrolizumab
Name: ShangHai DC Chemicals Co.,Ltd
Area: China
Price:
$450.0/10mg
$700.0/25mg
Contact: Tony Lai
Product Detail: Pembrolizumab
Get all suppliers by the below link:
2024-07-15 Pembrolizumab
2022-11-29 Pembrolizumab
2023-10-30 Pembrolizumab
2023-05-17 Pembrolizumab
2024-05-16 Pembrolizumab
2022-05-12 pembrolimumab
2023-04-03 Pembrolizumab biosimilar
2024-04-03 Pembrolizumab
2023-11-18 Lambrolizumab
Get all price from the following link: